PharmaSGP Holding Stock

PharmaSGP Holding Net Income

The The Net Income of PharmaSGP Holding (PSG.DE) as of Mar 13, 2026 is 25.92 M EUR. In the previous year, The Net Income was 22.65 M EUR — a change of 14.44% (higher).

Net Income

25.92 MEUR

YoY

14.44%

Last updated: Mar 13, 2026

In 2026, PharmaSGP Holding's profit amounted to 25.92 M EUR, a 14.44% increase from the 22.65 M EUR profit recorded in the previous year.

The PharmaSGP Holding Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

NET INCOME (M EUR)
Date
NET INCOME (M EUR)
Jan 1, 2017
11.78 base
Jan 1, 2018
14.73 base
Jan 1, 2019
16.71 base
Jan 1, 2020
10.64 base
Jan 1, 2021
10.69 base
Jan 1, 2022
11.95 base
Jan 1, 2023
16.4 base
Invalid Date
19.08 base
Invalid Date
22.65 base
Invalid Date
25.92 base
Invalid Date
0 base
YEARNET INCOME (M EUR)
2027 est -
2026 est 25.92
2025 est 22.65
2024 est 19.08
2023 16.4
2022 11.95
2021 10.69
2020 10.64
2019 16.71
2018 14.73
2017 11.78

PharmaSGP Holding Revenue

PharmaSGP Holding Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2017
53.06 M EUR
15.32 M EUR
11.78 M EUR
Jan 1, 2018
60.6 M EUR
19.55 M EUR
14.73 M EUR
Jan 1, 2019
62.57 M EUR
22.36 M EUR
16.71 M EUR
Jan 1, 2020
63.25 M EUR
14.63 M EUR
10.64 M EUR
Jan 1, 2021
65.34 M EUR
15.8 M EUR
10.69 M EUR
Jan 1, 2022
85.82 M EUR
17.78 M EUR
11.95 M EUR
Jan 1, 2023
101.1 M EUR
24.64 M EUR
16.4 M EUR
Invalid Date
115.49 M EUR
31.31 M EUR
19.08 M EUR
Invalid Date
124.63 M EUR
37.77 M EUR
22.65 M EUR
Invalid Date
134.23 M EUR
41.11 M EUR
25.92 M EUR
Invalid Date
144.4 M EUR
45.25 M EUR
0 EUR

PharmaSGP Holding Margins

PharmaSGP Holding stock margins

The PharmaSGP Holding margin analysis displays the gross margin, EBIT margin, as well as the profit margin of PharmaSGP Holding. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for PharmaSGP Holding.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2017
91.27 %
28.87 %
22.21 %
Jan 1, 2018
89.27 %
32.26 %
24.31 %
Jan 1, 2019
90.62 %
35.74 %
26.7 %
Jan 1, 2020
90.19 %
23.14 %
16.82 %
Jan 1, 2021
90.07 %
24.18 %
16.36 %
Jan 1, 2022
89.48 %
20.71 %
13.93 %
Jan 1, 2023
90.64 %
24.37 %
16.22 %
Invalid Date
90.64 %
27.11 %
16.52 %
Invalid Date
90.64 %
30.31 %
18.17 %
Invalid Date
90.64 %
30.62 %
19.31 %
Invalid Date
90.64 %
31.34 %
0 %

PharmaSGP Holding Stock analysis

What does PharmaSGP Holding do? PharmaSGP Holding SE is a leading European company specializing in the marketing of over-the-counter and natural pharmaceuticals. The company was founded in 2009 and is headquartered in Gräfelfing near Munich. The history of PharmaSGP began with the vision of founder and CEO Alexander Kurz, who believed that many people were looking for natural alternatives to pharmaceuticals. Kurz founded PharmaSGP with the goal of developing natural health products that help people improve their health and well-being. PharmaSGP's business model focuses on the marketing of over-the-counter and natural pharmaceuticals through pharmacies, drugstores, and online sales. The company has a strong presence in Europe and is also expanding into other regions worldwide. PharmaSGP is divided into three divisions: Consumer Healthcare, Medical Devices, and Healthcare Services. The Consumer Healthcare division offers natural health products and dietary supplements targeting consumers. The company has developed a wide range of products specifically tailored to the needs of people at different stages of life, from pregnancy and breastfeeding to old age. In the field of medical devices, PharmaSGP focuses on the development and marketing of innovative medical devices and technologies tailored to the needs of healthcare professionals. The company has developed a range of medical devices such as medication dispensers or blood glucose meters to facilitate disease treatment. In the Healthcare Services division, the company also offers services such as medical consulting and patient management. This involves holistic patient care, offering various services to ensure effective and comprehensive treatment. PharmaSGP also has an impressive range of products covering various health areas. There are products for dietary supplementation, sleep support, pain therapy, and cold relief, to name just a few. One of PharmaSGP's most well-known products is Yokebe, a natural meal replacement that can help reduce weight. The company is committed to ensuring the quality of its products and therefore works closely with scientists and healthcare professionals to ensure that all products are based on current scientific knowledge and studies. In summary, PharmaSGP is an innovative company focused on the marketing of natural and over-the-counter pharmaceuticals. It has developed a wide range of products and services specifically tailored to the needs of consumers and healthcare professionals. The company is committed to continuously improving the quality of its products and services and works closely with scientists and healthcare professionals to ensure comprehensive patient care. PharmaSGP Holding is one of the most popular companies on Eulerpool.com.

Net Income Details

Understanding PharmaSGP Holding's Profit Margins

The profit margins of PharmaSGP Holding represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of PharmaSGP Holding's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating PharmaSGP Holding's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

PharmaSGP Holding's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When PharmaSGP Holding’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about PharmaSGP Holding stock

The Net Income of PharmaSGP Holding amounted to 22.65 M EUR 25.92 M

The profit in evaluating a stock

History, usage, calculation, and application of earnings in securities trading.

The history of earnings dates back to the beginnings of modern business organization. Since the beginning of industrialization, companies have been established to generate profits, and profits have been considered an essential part of corporate management. In recent years, the importance of earnings for investors has continued to rise, as many investors seek to find stocks that generate solid earnings.

Use of Profits

In securities trading, profits are used to determine the value of a stock. A company that generates profits is considered financially healthy and its stocks are valued higher, while a company that does not generate profits is considered less reliable and therefore receives a lower valuation. Investors can review the profits of each company by examining the relevant documents such as the income statement, the annual financial statements, and the income tax audits.

Calculation of profits

There are several different ways to calculate profits. The simplest way to calculate profits is by calculating net earnings. Net earnings are calculated by subtracting the company's expenses from its revenue. Another way to calculate profits is by calculating operating income. Operating income is calculated by subtracting the company's materials costs and employee wages and salaries from its revenue.

Use of profits

There are many different ways in which investors can use profits when evaluating stocks. One example is calculating the price-to-earnings ratio (P/E ratio). The P/E ratio is the relationship between the price of a stock and the company's earnings. When calculating the P/E ratio, the stock price is divided by the company's earnings. A low P/E value indicates that the stock has a good price-performance ratio, and a high P/E value indicates that the stock has a poor price-performance ratio.

Advantages and disadvantages of using profits

There are many advantages to using earnings in securities trading. Firstly, investors can check the financial health of a company by analyzing earnings. Secondly, investors can make a better decision about the valuation of a stock by calculating the P/E ratio. Thirdly, investors can reduce their risk by choosing stocks with a low P/E ratio.

However, there are also some drawbacks to relying on profits. Firstly, profits can be distorted if a company increases its profits through cost-cutting measures. Secondly, profits can present an inaccurate picture of a company's financial health if they are not calculated correctly. Thirdly, profits may not always be a reliable indicator of a company's future, as they can easily fluctuate.

t('components_kpi_Explanation_34')

Overall, it can be said that profits in securities trading are an important indicator of a company's financial health. Investors can analyze profits to get a better understanding of the company's financial health and make informed decisions about stock valuation. However, there are some disadvantages to using profits as they can sometimes be distorted or inaccurate. Therefore, it is important for investors to be cautious and carefully analyze profits before making a decision to buy or sell stocks.

Income Statement — PharmaSGP Holding

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

All Key Metrics — PharmaSGP Holding